Chemcon Speciality Chemicals files Rs 350 crore IPO papers with SEBI
The key customers of the company's pharmaceutical chemicals include Hetero Labs, Laurus Labs, Aurobindo Pharma and IndSwift Laboratories. The shares of the company will be listed on the BSE and the NSE.
New Delhi: Chemcon Speciality Chemicals, a leading manufacturer of pharmaceutical chemicals, has filed draft papers with market regulator Sebi for its proposed initial public offer to raise about Rs 350 crore. The issue comprises a fresh issue of Rs 175 crore and an offer for sale of 43 lakh equity shares from the promoters, according to the draft red herring prospectus (DRHP).
As per market sources, the initial public offer (IPO) size is about Rs 350 crore.
Read Also: JB Chemicals gets zero USFDA observations for Panoli unit
Intensive Fiscal Services and Ambit Capital are the managers of the offer.
The Baroda-based company supplies its products to domestic customers and also export to countries including the US, China, Japan, UAE, Azerbaijan, Serbia, Russia and Malaysia, as per the DRHP.
The key customers of the company's pharmaceutical chemicals include Hetero Labs, Laurus Labs, Aurobindo Pharma and IndSwift Laboratories. The shares of the company will be listed on the BSE and the NSE
Read Also: Ipca Labs to acquire Ramdev Chemical for Rs 108 crore
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd